Absci Corporation (ABSI) NASDAQ
5.20
+0.245(+4.95%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Absci Corporation
Address
18105 SE Mill Plain Boulevard
Vancouver, WA 98683
United States of America (the)
Phone
360 949 1041
Website
Sector
Healthcare
Industry
Biotechnology
Employees
156
First IPO Date
July 22, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Sean McClain | Founder, Chief Executive Officer, President & Director | 1.08M | 1990 |
| Zachariah Jonasson | Chief Business Officer & Chief Financial Officer | 816,507 | 1973 |
| Amir Shanehsazzadeh | Chief AI Officer | 0 | N/A |
| Amer-Denis Akkad | Vice President of Research | 0 | N/A |
| Anders Kassow | Head of Intellectual Property | 0 | N/A |
| Christine Lemke | Senior Vice President of Portfolio & Growth Strategy | 0 | N/A |
| Ransi Somaratne FACC | Chief Medical Officer | 0 | 1966 |
| Melissa Patterson | Chief of Staff | 0 | N/A |
| Todd Bedrick | Senior Vice President & Chief Accounting Officer | 0 | N/A |
| Karin Wierinck | Chief People Officer | 0 | N/A |
| Shelby Walker | Chief Legal Officer | 0 | 1975 |
| Wen Sha | Chief of Staff | 0 | N/A |
| Alexander Khan | CVP of Finance & Head of Investor Relations | 0 | N/A |
| Jeanne Schreuder SPHR | Senior Vice President of People & Experience | 0 | N/A |
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
